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The Role of Hypothyroidism in the Etiology and Progression of
Dilated Cardiomyopathy in Doberman Pinschers
P. Beier, S. Reese, P.J. Holler, J. Simak, G. Tater, and G. Wess
Background: Hypothyroidism and dilated cardiomyopathy (DCM) are both common diseases in Doberman Pinschers.
A possible influence of hypothyroidism on the etiology and progression of DCM is controversial.
Objectives: Evaluation of the role of hypothyroidism in etiology and progression of DCM.
Animals: A total of 175 Doberman Pinschers.
Methods: In this longitudinal prospective study, echocardiography and 24-hour ambulatory ECG recordings were per-
formed in all dogs as screening tests for DCM. Total thyroxine (TT4) and thyroid ultrasonography served as initial screen-
ing tests for hypothyroidism and low TT4 values were followed up by a thyroid stimulating hormone (TSH) test or free
total thyroxine (fT4)/cTSH measurements. Additionally, a follow-up study of dogs affected by both DCM and hypothy-
roidism under optimal treatment for hypothyroidism was conducted.
Results: A total of 107 dogs were healthy, 45 dogs had DCM, 11 hypothyroidism, and 12 dogs had both DCM and
hypothyroidism. TT4 values as well as the thyroid volumes were equivalent in the healthy dogs and in those with DCM.
Neither ventricular premature complexes nor echocardiographic parameters differed between healthy and hypothyroid
dogs. Dogs with DCM had a 2.26-fold (CI0.95 = 1.1–4.8) higher risk of also being affected by hypothyroidism. Despite
optimal thyroid treatment of dogs with hypothyroidism and DCM, there was a progression of the heart disease.
Conclusions and Clinical Importance: This study did not confirm a role of hypothyroidism in the etiology or progres-
sion of DCM. Treatment of hypothyroidism did not improve the clinical outcome.
Key words: Dogs; Echocardiography; Euthyroid sick syndrome; Thyroid sonography.
Dilated cardiomyopathy (DCM) is the mostcommon acquired cardiac disease in large and
giant-breed dogs.1,2 Certain breeds, like the Doberman
Pinscher, are overrepresented.2–4 The reported cumula-
tive prevalence of DCM in Dobermans is 58.2%. The
authors calculated a cumulative prevalence, because
the prevalence differs in various age groups.5 Because
of familial clustering, an autosomal dominant inheri-
tance is suspected regarding this breed.5,6
Besides a familial or genetic etiology of DCM,
several other etiologies are known to cause secondary
cardiomyopathies, including nutritional, inflamma-
tory, infectious, infiltrative, ischemic, and drug- or
toxin-induced myocardial diseases.2 Furthermore,
immunologic abnormalities, biochemical alterations,
tachycardia-induced cardiomyopathies, and metabolic
disorders can be causative.2 One of these possible
metabolic disorders is hypothyroidism, which is one of
the most common endocrine disorders in dogs.7,8
Doberman Pinschers are particularly prone to develop
hypothyroidism.9
Thyroid hormones have positive inotropic and chro-
notropic effects.7 They multiply the number of beta-
adrenergic receptors and increase their affinity and the
response to catecholamines.7,10 The inotropic state of
the left ventricle seems to be related to the thyroid
state in experimental conditions and also in hypothy-
roid dogs undergoing medical treatment.11,12 In case of
hormone deficiency, reduced left ventricular systolic
function, low QRS voltages, inverted T waves, weak
apex beat, and sinus bradycardia are common cardio-
vascular abnormalities.7,13,14 Therefore, it has been
assumed that hypothyroidism might play a role in the
development or progression of DCM.10 Other studies,
however, have failed to show a relationship between
these 2 diseases.4,15 No relation could be detected
between hypothyroidism and DCM in Doberman Pin-
scher dogs.16 A common problem encountered in vet-
erinary practice is the euthyroid sick syndrome (ESS),
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BSA body surface area
BW body weight
cTSH canine thyroid stimulating hormone
DCM dilated cardiomyopathy
DCPAH Diagnostic Center for Population and Animal Health
ESS euthyroid sick syndrome
FS fractional shortening
fT4 free total thyroxine
Holter 24-hour ambulatory ECG
LVEDV left ventricular end-diastolic volume
LVESV left ventricular end-systolic volume
LV left ventricle
RR relative risk
RTV relative thyroid volume
SMOD Simpson method of disc




TV total thyroid volume
VPCs ventricular premature complexes
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also known as sick euthyroid syndrome, which refers
to a state, where concurrent nonthyroidal illness causes
suppression of serum concentrations of circulating thy-
roid hormone without true pathology of the thyroid
gland. Decreased concentrations of total thyroxine
(TT4) and to a lesser degree free total thyroxine (fT4)
in ESS can be misleading and might result in an erro-
neous diagnosis of hypothyroidism.17 ESS has been
described to occur with various cardiac diseases,17 for
example, in Doberman Pinschers with CHF.16 Thyroid
sonography is an effective tool to discriminate between
hypothyroid and euthyroid sick dogs.18
Because there are still many controversial discus-
sions as well as different opinions regarding DCM and
hypothyroidism, the diagnosis of DCM might be
delayed and some dogs with DCM might receive only
treatment for hypothyroidism, but not for their cardiac
disease. Some owners or veterinarians are reluctant to
give cardiac drugs, because they think that treatment
for hypothyroidism would be sufficient. These dogs
might have potentially life-threatening arrhythmias or
a morphologically abnormal heart. A treatment of
these changes would not only prolong their lives but
could also increase their quality of life.19
Therefore, the aim of this study was to examine if
hypothyroidism has a modifying affect on the onset
and clinical course of DCM in a large cohort of
Doberman Pinschers. Furthermore, the therapeutic
benefits of hypothyroidism treatment on the clinical
outcome and the presence of ESS in different stages of
DCM were evaluated.
Material and Methods
Study Design and Animals
This study was a prospective clinical trial from September
2011 to February 2013. Doberman Pinschers were recruited
according to the inclusion and exclusion criteria listed below.
The animals were all client-owned dogs. The study fulfilled the
general German guidelines for prospective studies with informed
owners’ consent. The study consisted of 2 parts: (1) Assessment
of DCM and of hypothyroidism in Doberman Pinschers. (2) Fol-
low-up study of dogs affected by both DCM and hypothyroid-
ism, under optimal treatment for hypothyroidism.
Inclusion Criteria. The study included all Doberman Pinschers,
which were presented to the department of cardiology of the
Clinic of Small Animal Medicine, LMU University of Munich,
between September 2011 and February 2013. Main reasons for
the presentation of the dogs at the clinic were DCM screening
purposes or regular recheck visits, if they had been previously
diagnosed with DCM.
Exclusion Criteria. Dogs were excluded, if they had a severe
systemic (eg, acute kidney failure, sepsis) or chronic disease (eg,
diabetes mellitus, chronic kidney failure) of any kind other than
hypothyroidism or DCM. In nonthyroidal illness, the TT4 con-
centration tends to decrease and this complicates the diagnosis of
hypothyroidism.7,20 Furthermore, dogs participating in this study
were not allowed to receive corticosteroids, nonsteroidal anti-
inflammatory drugs, phenobarbital, or sulfonamides during the
whole study duration, because these drugs might influence the
thyroid gland.7,21,22 Besides DCM, all other congenital or
acquired heart diseases led to study exclusion.
Examinations. A detailed history was acquired and all dogs
were subject to a clinical examination.
Cardiac Examination. In all dogs, an in-house ECG, a 24-
hour ambulatory ECG (Holter), as well as a complete echocar-
diographic study, were performed. The ECGa was recorded in
right lateral recumbency according to standard technique. The
Holter recordings were analyzed with one of two commercial
software programs.b,c Manual adjustments and accuracy verifica-
tion of the arrhythmias recognized by the software were per-
formed. The presence and number of ventricular premature
complexes (VPCs) were recorded.
The echocardiography was performed in right and left lateral
recumbency in nonsedated dogs. A high frame rate ultrasound
systemd with a 2.0/4.3 MHz transducer was used. Left ventricular
volume was measured by Simpson’s method of discs (SMOD) in
the right parasternal long-axis view and additionally in the left
parasternal apical 4-chamber view. The end-diastolic and end-sys-
tolic LV volumes (LVEDV, LVESV) were indexed to body sur-
face area (BSA).23 For determination of the DCM status and the
statistical analysis only the larger value of both views was used.
Color-Doppler was used to search for congenital or acquired car-
diac diseases. Pulsed-wave Doppler was used to measure the
velocities over the aortic and the pulmonic valves. For inclusion
these velocities had to be <2.2 m/s. The follow-up interval for the
cardiac status was dependent on the observed findings. Healthy
dogs were rechecked once a year, the dogs with congestive heart
failure every 3–6 months, the others dependent on their needs.
The complete cardiac examination, inclusive echocardiography
and Holter were repeated.
Determination of the DCM Status. Dogs were classified
as having DCM, if LVEDV/BSA was >95 mL/m2 or LVESV/
BSA was >55 mL/m2.23 More than 100 VPCs in 24 hours in the
Holter-ECG were indicative of DCM.24 Dogs that had between
50 and 100 VPCs/24 hours and a normal echocardiographic
examination were considered equivocal and were not included in
the statistical analysis.23,24
Cardiac Treatment. All dogs with systolic dysfunction
received Pimobendan.e Depending on Holter results and the indi-
vidual disease progression, dogs received further medication,
either one drug or a combination of the following: Ramipril,f So-
talol Hydrochloride,g Amiodarone Hydrochloride,h Mexiletine.i
In case of decompensation (presence of pulmonary edema, pleu-
ral effusion, or ascites), Fursosemidej was added.
Investigation of Hypothyroidism. As a first screening test,
a thyroid ultrasound and TT4 measurements were performed.
Plasma TT4 concentrations were measured with a chemilumines-
cent enzyme immunoassay. The reference range was 12.9–
51.5 nmol/L (1.0–4.0 lg/dL).
The thyroid sonography was performed by an experienced
investigator (SR) in a quiet room, with unsedated dogs in a sit-
ting position. One of two high frame rate ultrasound systems
(My Lab Twice and My Lab 40k ) with a 7.5–13 MHz linear
array probel was used. Thyroid glands were scanned in longitudi-
nal and transversal planes. Size, echogenicity, and homogeneity
of the thyroid lobes were examined.7 The thyroid lobe volume
was calculated and related to metabolic weight (BW0.75). A rela-
tive thyroid volume (RV) <0.05 mL/kg0.75 was indicative of
hypothyroidism.18
Dogs with a TT4 below the reference range or an abnormal
thyroid ultrasound received one or several additional thyroid
tests. In agreement with the owners and if the dogs were not yet
under treatment for hypothyroidism, a TSH-stimulating test was
performed.7 For this test, TT4 was measured before and 6 hours
after the administration of 150 lg/dog recombinant human TSH
(thyrotropin alpha).m ,[25] The results of the TSH-stimulation
tests were interpreted according to criteria established in
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previously published studies.25,26 Briefly, a poststimulation TT4
concentration of >2.5 lg/dL and values being at least 1.5 times
the basal TT4 concentration were considered a normal euthyroid
test result. TSH-stimulation test results with post-TSH TT4 con-
centrations between 1.6 and 2.5 lg/dL and a post-TSH TT4 con-
centration of >1.5 times basal TT4 in dogs without clinical signs
of hypothyroidism were also considered normal in this study.
Dogs with post-TSH TT4 concentrations of <1.6 lg/dL and <1.5
times the basal TT4 were classified as hypothyroid. Additionally,
all blood samples of dogs with low or high TT4, altered thyroid
sonography, or both were sent to the Diagnostic Center for Pop-
ulation and Animal Health (DCPAH) at Michigan State Univer-
sity, to run a detailed canine thyroid diagnostic profile,n
including fT4 by equilibrium dialysis, canine TSH (cTSH), thyro-
globulin autoantibodies (TgAA), and autoantibodies directed
against TT4 (T4AA). Dogs with a low TT4, but a normal thyroid
profile as well as a normal thyroid ultrasound, were classified as
euthyroid.
Determination of the Thyroid Status. Dogs were classi-
fied as hypothyroid, (1) if they had a positive TSH-stimulation
test; (2) if they had a TT4 value below the reference range and a
cTSH higher than the reference range; or (3) if they were pre-
sented under treatment, the relative thyroid volume had to be
<0.05 mL/kg0.75 and they had to have a reduced echogenicity
and homogeneity of the thyroid gland.18,27 Ongoing treatment
for hypothyroidism was not stopped to confirm the diagnosis of
hypothyroidism, if it was likely that these dogs suffer from hypo-
thyroidism (relative thyroid volume <0.5 mL/kg0.75), because it
was considered to be unethical. Dobermans were classified as
euthyroid if (1) TT4 was within the reference range and the thy-
roid sonography showed no abnormalities; or if (2) TT4 and the
thyroid profile were normal and no evidence of clinical signs of
hypothyroidism, despite an abnormal relative thyroid volume,
but normal echogenicity and homogeneity.
The thyroid status was declared questionable, if the value of
TT4 was low or high and there was no confirmatory test possible.
Dogs were classified as euthyroid sick, if they had a low TT4 only
and DCM. The rest of the thyroid diagnostics were normal in
this case. The term ESS was also used in previously published
studies to describe a low TT4 in combination with a nonthyroidal
illness.18,20,28 In Figure 1, the determination of the thyroid status
is displayed graphically.
Treatment of Hypothyroidism. Once hypothyroidism was
confirmed, the dogs received a starting dose of 0.02 mg/kg
Levothyroxineo 2 times a day. The TT4 was rechecked 4 weeks
after starting treatment—6 hours after tablet administration. If
Fig 1. Flowchart to demonstrate the determination of the thyroid status. Pos. TSH test, positive test result in the thyroid stimulating
hormone test; TT4, total thyroxine; TS, thyroid sonography; cTSH, canine TSH; DCM, dilated cardiomyopathy; ESS, euthyroid sick
syndrome.
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necessary, the treatment was adjusted. Treatment was considered
optimal, if the value of TT4 was in the upper part or slightly
above the reference range.29 If dogs were in congestive heart fail-
ure (CHF), the starting dose was reduced to 0.01 mg/kg Levothy-
roxine 2 times a day, because of potential worsening of heart
failure by restoring the euthyroid state.30
Group Classification and Statistical Analysis
Two commercially available software programs were used for
statistical analysis.p,q According to the initial examination of each
dog, dogs were assigned to one of the four following groups: (1)
healthy, (2) DCM, (3) hypothyroidism, or (4) DCM + hypothy-
roidism. These 4 groups were applied for all further investiga-
tions. Relative frequencies, as well as relative risks (RRs) and
95% confidence intervals, were calculated.31 The RR is the ratio
of the probability of an event occurring in an exposed group to
the probability of the event occurring in a comparison, nonex-
posed group. It is used to compare the risk of developing a dis-
ease.31,32 To compare the prevalence of hypothyroidism in the
healthy versus the DCM group, we used the chi-square test.31
The influence of age and the SMOD results were examined using
a 1-way ANOVA test and posthoc Bonferroni correction. Stu-
dent’s t-test for independent samples was used to analyze the
influence of weight and to investigate the results of the thyroid
sonography. The influence of VPCs in the different groups was
evaluated with the Kruskal-Wallis test and a posthoc Mann-
Whitney U-test. To test equivalence, the equivalence test for aver-
ages by Schneider was used.33 Furthermore, the effect sizes and
their 95% confidence intervals of age, TT4, thyroid sonography,
and SMOD values were determined. An effect size (Cohen’s d)
>0.80 is indicative for a great influence of the disease status on
the examined parameter.34
As a second part of the study, the course of the heart disease
of those dogs affected by both DCM and hypothyroidism was
evaluated. A paired t-test was used to compare SMOD values
before and under hypothyroidism treatment; additionally a Wil-
coxon test was used to examine the number of VPCs between the




A total of 184 Doberman Pinschers were examined
during the study period; 175 Doberman Pinschers with
a median body weight of 35.0 kg (range 22.6–49.8 kg)
and a median age of 6.00 years (range 1–13 years) ful-
filled the inclusion and exclusion criteria. Eight dogs
were excluded because their cardiac status was ambig-
uous. They were neither definitely ill nor healthy. One
dog was excluded because of a TT4 above the reference
range and no follow-up. Ninety-seven (55.1%) of the
175 dogs were female and 78 (44.9%) male. At the
time of study inclusion, 118/175 (67.4%; CI0.95 = 60.4–
74.3%) of the dogs had a normal cardiac examination
including echocardiography and Holter, 57 (32.6%)
dogs were diagnosed with DCM. Of the dogs with
DCM, 17 (9.7%) dogs had only VPCs, 20 (11.4%)
dogs showed only echocardiographic changes, and 12
(6.9%) patients had both VPCs and echocardiographic
changes. Eight (4.6%) dogs were in CHF. Six of the
CHF dogs had VPCs and echocardiographic changes,
the remaining 2 dogs only had echocardiographic
changes. Hypothyroidism was diagnosed in 23 (13.1%)
Doberman Pinschers. The results of the thyroid classi-
fication and how the diagnosis was made are shown in
Figure 2. According to a combined thyroid and car-
diac status, the dogs were assigned to one of the 4
groups as mentioned earlier: (1) healthy (n = 107,
61.1%), (2) DCM only (n = 45, 25.7%), (3) hypothy-
roidism only (n = 11, 6.3%), and (4) DCM + hypothy-
roidism (n = 12, 6.9%). Table 1 shows the mean, or
the median and the range of the examined cardiac and
thyroid parameters in the 4 groups. Table 2 shows the
same parameters, but split up by the DCM status for
the DCM + hypothyroidism and the DCM only
group. The prevalence of hypothyroidism was higher
in the DCM group (12/57, 21.1%) compared with the
healthy group (11/118, 9.3%) in this study (P = .031).
Seven dogs in this study had DCM and a low TT4
and were classified as ESS.
Relative Risk
A Doberman Pinscher, diagnosed with hypothyroid-
ism, has a 1.76-fold (CI0.95 = 1.1–3.0) increased risk to
develop DCM. Furthermore, a dog suffering from
DCM has a 2.26-fold (CI0.95 = 1.1–4.8) increased risk
to develop hypothyroidism.
Group Comparisons
Age and Body Weight. Healthy dogs (median:
5.00 years) were significantly (P < .001) younger than
dogs diagnosed with DCM (median: 7.00 years) or
with DCM + hypothyroidism (median: 9.00 years).
Hypothyroid dogs had a median age of 6.00 years and
were significantly (P = .036) younger than the
DCM + hypothyroidism group. The hypothyroid dogs
(mean weight: 38.35 kg) were 9% heavier (P = .027)
than the healthy dogs (mean weight: 34.54 kg). Dogs
belonging to the DCM + hypothyroidism group had a
mean body weight of 37.18 kg, whereas dogs in the
DCM only group had a mean weight of 36.62 kg—not
statistically significant (P = .770).
Cardiac Variables. Regarding the number of VPCs/
24 hours, there was neither a difference between
healthy (median: 1.00) and hypothyroid dogs (median:
1.00) (P = .514), nor a statistically significant
(P = .394) difference between dogs with DCM (med-
ian: 249.00) and dogs with both, DCM and hypothy-
roidism (median: 155.00). Dogs with DCM or both
diseases had significantly more VPCs than healthy or
hypothyroid dogs (P < .001).
There was no significant difference of LVEDV/BSA
and LVESV/BSA between the healthy and the hypothy-
roid group (P = 1.00). However, both groups had signif-
icantly smaller LVEDV/BSA and LVESV/BSA SMOD
values compared with both, the DCM group and the
DCM + hypothyroidism group (for all P < .001,
Table 1). There was no significant difference in heart
size between the DCM and the DCM + hypothyroidism
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group assessed by LVEDV/BSA (P = .130) and
LVESV/BSA (P = .294). With respect to LVEDV/BSA
statistical equivalence between these groups was demon-
strated (P = .050). The effect sizes, showing the influ-
ence of hypothyroidism on SMOD values, were low
(d = 0.34 LVEDV/BSA (CI0.95 = 0.28 to 0.96),
d = 0.63 LVESV/BSA (CI0.95 = 0.00–1.25) healthy ver-
sus hypothyroid dogs, d = 0.48 LVEDV/BSA (CI0.95
= 0.17 to 1.1), d = 0.39 LVESV/BSA (CI0.95 = 0.25
to 1.03) DCM versus DCM + hypothyroidism group).
Therefore, these low effect sizes indicate no relevant
influence of hypothyroidism on the SMOD values.
Thyroid Variables. The TT4 measurements of
healthy dogs and dogs suffering from DCM were
equivalent (P = .050). The effect sizes of the hypothy-
roid group versus DCM + hypothyroidism group
(d = 0.28 [CI0.95 = 0.55 to 1.09]) and the healthy ver-
sus the DCM group (d = 0.010 [CI0.95 = 0.34 to
0.36]) were very low and consequently indicate no
influence of DCM on TT4 values. A low TT4 value
Fig 2. Flowchart to show the results of the classification of the thyroid status. TT4, total thyroxine; TS, thyroid sonography; TSH test,
thyroid stimulating hormone test; fT4, free T4; cTSH, canine TSH; hypo, hypothyroid; n, number of dogs; DCM, dilated cardiomyopa-
thy; VPCs, ventricular premature complexes; Only ECHO, only echocardiographic changes; ESS, euthyroid sick syndrome.
Table 1. Mean or median and range of total thyroxine (TT4), relative thyroid volume (RV), the number of Holter
ventricular premature complexes (VPCs), and Simpson method of disc left ventricular end-systolic and end-dia-










TT4 (nmol/L), mean (range) 19.54 (9.01–45.04) 19.59 (9.01–34.75) 10.06 (9.01–11.58) 9.76 (9.01–11.58)
RV (mL/kg0.75), mean (range) 0.08 (0.04–0.18) 0.07 (0.05–0.13) 0.05 (0.03–0.10) 0.05 (0.02–0.10)
Holter VPCs, median (range) 1 (0–49) 249 (0–16,512) 1 (0–5) 155 (0–53,815)
LVEDV/BSA (mL/m2), mean (range) 79.85 (55.50–94.90) 105.08 (68.20–207.90) 76.75 (69.90–89.20) 119.31 (78.31–191.10)
LVESV/BSA (mL/m2), mean (range) 40.60 (17.20–54.80) 64.96 (33.20–154.00) 35.77 (25.10–50.40) 75.73 (35.03–164.10)
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was documented in 13.1% of the healthy dogs and in
15.6% of the dogs in the DCM group.
Total and relative thyroid volume (TV, RV) of dogs
suffering from DCM and healthy dogs was statistically
equivalent (P = .050). Hypothyroid dogs had a signifi-
cant smaller TV (P = .0021) and RV (P < .001) than
healthy dogs or those affected with DCM (TV:
P = .0080, RV: P < .001). Furthermore, dogs suffering
from both diseases showed likewise a significant differ-
ence compared with healthy (P < .001) and DCM dogs
(P < .001). Again, the effect sizes of the hypothyroid
group versus DCM + hypothyroidism group (d = 0.18
[CI0.95 = 0.65 to 0.99]) and the healthy versus the
DCM group (d = 0.16 [CI0.95 = 0.19 to 0.51]) were
low and indicate no relevant influence of DCM on the
thyroid sonography measurements.
Follow-up Examinations. Eight of the twelve dogs
included in the DCM + hypothyroidism group were
presented for a recheck examination (mean 4 months,
range 3–6 months). The second investigation was car-
ried out with optimal adjusted thyroid treatment (as
described in Material and Methods section). Three
dogs were newly diagnosed with hypothyroidism; 5
dogs had already been diagnosed with hypothyroidism
and treatment with Levothyroxine had been started
already. The remaining 4 dogs could not be rechecked,
because they died before the follow-up appointment.
Two dogs died because of congestive heart failure, one
because of sudden death and one dog was lost on fol-
low-up. The dogs showed significantly more VPCs at
the second examination (P = .018). Furthermore, the
SMOD values progressed significantly at the recheck
visit, as indicated by an increase of LVEDV/BSA
(P = .010) and LVESV/BSA (P = .021) compared to
the values of the first visit.
Discussion
Hypothyroidism and DCM are both common dis-
eases in Doberman Pinschers.5,12,35–37 Although it
appears that there might be a link between both
diseases according to the results of this study, which
showed that Doberman Pinschers with DCM have a
2.26-fold increased risk to develop hypothyroidism,
hypothyroidism does not seem to play a role in the
etiology or progression of DCM in this breed. This
statement is supported by several findings of the
present study, such as that there was no difference
in cardiac size or number of VPCs comparing the
healthy group and the hypothyroid group and also
by the ongoing deterioration of the SMOD values
and the number of VPCs despite optimal thyroid
treatment in dogs affected by both DCM and
hypothyroidism.
The role of hypothyroidism regarding the etiology
of DCM is discussed controversially in the literature.
Several authors state that hypothyroidism leads to
impaired left ventricular function in dogs.7,13,14 The
same finding is described in the human literature.38–41
However, this systolic dysfunction is rarely clinically
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in the human literature,39,45–47 some authors suspected
that hypothyroidism could exacerbate a preexisting
myocardial dysfunction and even lead to heart failure.
Because of this, hypothyroidism was mentioned to
possibly cause DCM in dogs10,48 and in humans.49–51
Other veterinary studies, however, could not identify a
relationship between hypothyroidism and cardiomyop-
athy with or without congestive heart failure, including
a study in Doberman Pinschers.15,16,52,53 In the present
study, we did not find a significant difference in car-
diac size between the healthy and the hypothyroid
group and there was also no difference between the
DCM and DCM + hypothyroidism group. Also,
whereas in a few cases an improvement of cardiac
function has been reported under thyroid treatment,42–
44 no improvement of the cardiac variables or at least
a disease standstill was observed in the dogs of the
DCM + hypothyroidism group in the follow-up study
under optimal adjusted thyroid treatment. These
results speak clearly against a role of hypothyroidism
in the etiology or progression of DCM in Doberman
Pinschers.
A feature of DCM in Doberman Pinschers is the
common presence of VPCs and ventricular tachyar-
rhythmias.24 In humans, malignant ventricular ar-
rhythmias are reported to occur in some patients with
hypothyroidism.54,55 However, these ventricular ar-
rhythmias seem to disappear with thyroid treatment in
humans.56,57 Assuming hypothyroidism would cause
VPCs in dogs and potentially by doing that a second-
ary tachycardia-induced DCM, one would expect to
find more VPCs in dogs with only hypothyroidism.
However, in the present study, there was neither a sig-
nificant difference regarding the number of VPCs
between the healthy and the hypothyroid nor the
DCM and the DCM + hypothyroidism group. Addi-
tionally, in the follow-up study, the VPCs did not dis-
appear under thyroid treatment; they even became
more severe. Therefore, according to the results of our
study, VPCs in Dobermans are related to DCM and
not to hypothyroidism.
The published all-breed prevalence of hypothyroid-
ism is between 0.2 and 0.8%.9,10,12 Doberman Pins-
chers have an increased risk to be additionally
affected by hypothyroidism12,35,36 and this is in agree-
ment with the results of the current study, in which
the relative frequency of hypothyroidism in Dober-
man Pinschers was 13.1%. Whereas the incidence of
hypothyroidism in the DCM group (21.1%) was
higher than in the healthy group (9.2%) in the pres-
ent study, one study reported that the prevalence of
hypothyroidism in the DCM group was not higher
compared with the group with noncardiac diseases.16
An explanation for this discrepancy might be the sig-
nificantly lower age of the healthy group in the cur-
rent study, as the average age at diagnosis of
hypothyroidism is 7 years9,10,12 and DCM in Dober-
man Pinschers is also more frequently diagnosed in
older dogs.2,5 Therefore, it is not surprising that
hypothyroidism was more often diagnosed in the
DCM group compared with the healthy group.
Whereas hypothyroidism did not play a role in the
etiology or progression of DCM in this study, we
found that the RR to be additionally affected by
DCM was increased in hypothyroid dogs. Dogs suffer-
ing from DCM even have a 2.26-fold higher risk to be
also affected by hypothyroidism. One possible explana-
tion could be that Doberman Pinschers have a breed
predisposition for both diseases, independent from
each other. Thus, there might be a more frequent joint
occurrence of the two diseases, without having a cau-
sal relationship.10 This hypothesis is strengthened by
the fact that both diseases tend to affect older dogs
and the dogs in the healthy group in this study were
significantly younger. Another possibility might be a
common pathway in the pathogenesis of both diseases
as, for example, an immune-mediated origin. Immuno-
logic processes might play a role in the pathogenesis of
DCM,1,2,58,59 as well as in the development of hypo-
thyroidism,7,60 but further studies are needed to con-
firm this hypothesis.
Euthyroid sick syndrome is a condition in dogs,
where concurrent nonthyroidal illness causes suppres-
sion of serum concentrations of circulating thyroid
hormone without true pathology of the thyroid
gland. Decreased concentrations of TT4, and to a les-
ser degree fT4, with ESS can be misleading and result
in an erroneous diagnosis of hypothyroidism.17
According to the results of our study, ESS appears
to be an uncommon finding in Doberman Pinschers
with DCM. Low TT4 values were detected in 14 dogs
in the control group and 7 dogs in the DCM group,
in which the confirmatory thyroid function tests ruled
out hypothyroidism. Therefore, 7 dogs would fulfill
the criterion for ESS, but it is questionable whether
this represents real ESS because of DCM or low TT4
values attributable to other reasons, like in the
healthy group. Possible other origins for low TT4 val-
ues are normal fluctuation,61 extreme exercise,20 and
inadequate caloric intake.62 Speaking against ESS is
the fact that the TT4 values as well as the percent-
ages of low TT4 dogs in the healthy and DCM group
are similar (13.1%/15.6%). Additionally one would
suspect to find ESS more often in advanced DCM
stages17; however, this was not the case, as the 7
dogs are distributed to 3 of the 4 possible DCM sub-
groups. Because the thyroid sonography is an effec-
tive tool to discriminate between hypothyroid and
euthyroid sick,18 the thyroid gland of each dog was
scanned. The TV and RV did neither differ between
the healthy group and DCM group nor between the
hypothyroid group and the DCM + hypothyroidism
group. Consequently, DCM does not have any influ-
ence on thyroid sonography. If it is assumed that
hypothyroidism and DCM influence each other, there
should have been more abnormal thyroid sonograph-
ies in the DCM group.
A limitation of the study is that all dogs suffering
from cardiac disease received cardiac treatment
depending on their needs. Therefore, especially in the
DCM + hypothyroidism group, almost every dog
received a different treatment. But this cardiac treat-
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ment was not changed between the first and the
recheck examination. However, the influence of cardiac
treatment on the results cannot be ruled out com-
pletely. Another important limitation is the low num-
bers of dogs in the follow-up study; larger studies with
a control group should be conducted. Because of the
low number in the DCM + hypothyroidism group,
some confidence intervals of the effect sizes were very
wide. However, because all values of the effect sizes
are far away from the limit d > 0.80, which indicates a
great influence of the disease status on the examined
parameters, they are still convincing.34
In conclusion, this study shows that both hypothy-
roidism and DCM are common diseases in Doberman
Pinschers, but there is no influence of hypothyroidism
on the etiology and progression of DCM. Also, the
occurrence of an ESS is very uncommon in Doberman
Pinschers suffering from DCM with or without clinical
signs.
Footnotes
a Schiller Cardiovit AT-10; Schiller Medizintechnik Gmbh, Ger-
many
b Custo tera; Arcon Systems GmbH, Starnberg, Germany
c Amedtech ECGpro Holter software, EP 810 digital Recorder;
Medizintechnik Aue GmbH, Aue, Germany
d Vivid 7 dimension; General Electric Medial System, Waukesha,
WI
e Vetmedin; Boehringer Ingelheim, Ingelheim, Germany
f Vasotop; MSD Animal Health GmbH, Unterschleißheim,
Germany
g Sotalol-ratiopharm; Ratiopharm GmbH, Ulm, Germany
h Amiodaron 200; 1 A Pharma GmbH, Oberhaching, Germany
i Ritalmex 200; Valeant Pharmaceuticals International Inc. La-
val, QC
j Dimazon; MSD Animal Health GmbH, Unterschleißheim, Ger-
many
k Esaote_Piemedical, K€oln, Germany
l Lineararray type LA523; Esaote_Piemedical
mThyrogen, genzyme therapeutics; Genzyme corporation, Cam-
bridge, Mass, UK
n Premium canine thyroid profile, Order Code 20011
o Forthyron; Eurovet Animal Health B.V., Bladel, Netherlands
p PASW Statistics 18 SPSS for Windows, Version 13.0, SPSS
Inc., Chicago, IL
q MedCalc, Version 8.1, Mariakerke, Belgium
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